Aytu BioPharma (AYTU) 10-K2024 FY Annual report

Filed: 26 Sep 24, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absolute, accrual, analogy, arriving, backup, bad, Boulder, breakdown, Clawback, comfort, coupled, crafted, deferral, drawn, effectuating, email, ERC, faulty, fuel, gave, Halo, herewith, IAS, impersonation, impracticable, infrequently, IRC, Jian, joinder, Jonathan, judgement, landscape, manual, MFA, Middle, military, modern, nationwide, NEO, NIST, Oceanside, Organizational, Palestine, password, posture, prejudice, pretrial, recusing, resilience, resume, seat, slightly, stolen, TCJA, telephone, ticker, unbilled, undertook, unprofitable, vision

Removed: AcipHex, add, aerosol, affordability, Alternatively, amortizing, bear, breadth, card, carryforward, catheter, chronic, commence, confirmed, congenital, consented, constraint, consulted, counter, creativity, CVR, damaged, de, Deerfield, Department, depth, detectable, doubtful, effort, Encina, escalating, eventually, expedite, feet, fewer, Finally, fire, FlutiCare, foam, formulary, guide, HCP, heartburn, historic, hospital, hour, housed, hurt, impossible, inadvertent, incorporate, Index, initiation, inoperable, insufficient, irrevocably, Josh, Magna, manmade, MBA, measured, men, mice, modification, monograph, Moran, Natesto, newly, Novalere, outsource, permanent, pilot, Plante, PLLC, prospective, prospectively, protocol, qualitative, reducer, regain, regional, Regoxidine, Reluctance, remedial, repair, respiratory, scrutinized, sponsor, sponsoring, square, staffing, stay, subscription, subset, sustain, swingline, switch, tab, tornado, tradename, Treadway, tube, unamortized, underperforming, unexercised, unsupervised, vacate, VAP, viability, women

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated AYTU transcripts

AYTU similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated September 26, 2024, with respect to the consolidated financial statements included in the Annual Report of Aytu BioPharma, Inc. on Form 10-K for the year ended June 30, 2024. We consent to the incorporation by reference of said report into the Registration Statements of Aytu BioPharma, Inc. on Forms S-1 (File Nos. 333-212100, 333-213489, 333-222994, 333-223385, 333-227243, 333-227706 and 333-271556), on Forms S-3 (File Nos. 333-259862, 333-235548, 333-236599, 333-239010 and 333-265479) and on Forms S-8 (File Nos. 333-255325, 333-205462, 333-236598 and 333-272897).

/s/ GRANT THORNTON LLP

Denver, Colorado

September 26, 2024